Long-term Discontinuation of Dopamine Agonist Treatment in Patients with Prolactinomas Revisited
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term Discontinuation of Dopamine Agonist Treatment in Patients with Prolactinomas Revisited
Authors
Keywords
-
Journal
ARCHIVES OF MEDICAL RESEARCH
Volume -, Issue -, Pages 102893
Publisher
Elsevier BV
Online
2023-10-07
DOI
10.1016/j.arcmed.2023.102893
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Approach to the Patient With Prolactinoma
- (2023) Renata S Auriemma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Refractory lactotroph adenomas
- (2023) Sandrine A. Urwyler et al. Pituitary
- Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis
- (2022) Ida B. Andersen et al. CLINICAL ENDOCRINOLOGY
- Overview of the 2022 WHO Classification of Pituitary Tumors
- (2022) Sylvia L. Asa et al. ENDOCRINE PATHOLOGY
- Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors
- (2022) Renato Cozzi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
- (2019) Xiaoshuang Liu et al. Frontiers in Endocrinology
- Cabergoline Withdrawal Before and After Menopause: Outcomes in Microprolactinomas
- (2019) Rita Indirli et al. Hormones & Cancer
- The epidemiology, diagnosis and treatment of Prolactinomas:The old and the new
- (2019) Philippe Chanson et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors
- (2019) Sunita M C De Sousa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal
- (2018) Sandhya Santharam et al. CLINICAL ENDOCRINOLOGY
- A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with Cabergoline
- (2018) C E Stiles et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Management of dopamine agonist-resistant prolactinoma
- (2018) Dominique Maiter NEUROENDOCRINOLOGY
- Diagnosis and Treatment of Pituitary Adenomas
- (2017) Mark E. Molitch JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
- (2016) Sema Ciftci Dogansen et al. Pituitary
- Update on prolactinomas. Part 2: Treatment and management strategies
- (2015) Anni Wong et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline
- (2015) Shao Jian Lin et al. Oncotarget
- Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?
- (2015) Lucio Vilar et al. Frontiers in Endocrinology
- Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis
- (2014) Jintao Hu et al. Pituitary
- Giant prolactinomas: the therapeutic approach
- (2013) Aline B. Moraes et al. CLINICAL ENDOCRINOLOGY
- Second attempt to withdraw cabergoline in prolactinomas: a pilot study
- (2013) Ratchaneewan Kwancharoen et al. Pituitary
- Macroprolactinemia: Diagnostic, Clinical, and Pathogenic Significance
- (2012) Akira Shimatsu et al. Clinical & Developmental Immunology
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients
- (2009) Etienne Delgrange et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Recurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline Therapy
- (2009) J. Kharlip et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
- (2009) Olaf M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients
- (2008) Masami Ono et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now